Literature DB >> 29977089

Organoselenium-Based Entry into Versatile, α-(2-Tributylstannyl)vinyl Amino Acids in Scalemic Form: A New Route to Vinyl Stannanes.

David B Berkowitz1, Jill M McFadden1, Esmort Chisowa1, Craig L Semerad1.   

Abstract

Entities:  

Year:  2000        PMID： 29977089      PMCID： PMC6029884          DOI： 10.1021/ja0055110

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN： 0002-7863            Impact factor:   15.419


× No keyword cloud information.
  5 in total

Review 1.  Structural characteristics of alpha-helical peptide molecules containing Aib residues.

Authors:  I L Karle; P Balaram
Journal:  Biochemistry       Date:  1990-07-24       Impact factor: 3.162

2.  An Efficient Strategy to Orthogonally Protected (R)- and (S)-alpha-Methyl(alkyl)serine-Containing Peptides via a Novel Azlactone/Oxazoline Interconversion Reaction.

Authors:  Daniel Obrecht; Michael Altorfer; Christian Lehmann; Peter Schönholzer; Klaus Müller
Journal:  J Org Chem       Date:  1996-06-14       Impact factor: 4.354

3.  α-VINYLLYSINE AND α-VINYLARGININE ARE TIME-DEPENDENT INHIBITORS OF THEIR COGNATE DECARBOXYLASES.

Authors:  David B Berkowitz; Wan-Jin Jahng; Michelle L Pedersen
Journal:  Bioorg Med Chem Lett       Date:  1996-09-17       Impact factor: 2.823

4.  Engineering acyclic stereocontrol in the alkylation of vinylglycine-derived dianions: asymmetric synthesis of higher alpha-vinyl amino acids.

Authors:  D B Berkowitz; J M McFadden; M K Sloss
Journal:  J Org Chem       Date:  2000-05-19       Impact factor: 4.354

5.  Synthesis of [alpha-methyltyrosine-4]angiotensin II: studies of its conformation, pressor activity, and mode of enzymatic degradation.

Authors:  M C Khosla; K Stachowiak; R R Smeby; F M Bumpus; F Piriou; K Lintner; S Fermandjian
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205
  5 in total
  8 in total

1.  In situ enzymatic screening (ISES): a tool for catalyst discovery and reaction development.

Authors:  David B Berkowitz; Mohua Bose; Sungjo Choi
Journal:  Angew Chem Int Ed Engl       Date:  2002-05-03       Impact factor: 15.336

2.  Human serine racemase structure/activity relationship studies provide mechanistic insight and point to position 84 as a hot spot for β-elimination function.

Authors:  David L Nelson; Greg A Applegate; Matthew L Beio; Danielle L Graham; David B Berkowitz
Journal:  J Biol Chem       Date:  2017-07-10       Impact factor: 5.157

3.  In situ enzymatic screening (ISES) of P,N-ligands for Ni(0)-mediated asymmetric intramolecular allylic amination.

Authors:  David B Berkowitz; Weijun Shen; Gourhari Maiti
Journal:  Tetrahedron Asymmetry       Date:  2004-09-13

4.  Synthesis and Deployment of an Elusive Fluorovinyl Cation Equivalent: Access to Quaternary α-(1'-Fluoro)vinyl Amino Acids as Potential PLP Enzyme Inactivators.

Authors:  Christopher D McCune; Matthew L Beio; Jill M Sturdivant; Roberto de la Salud-Bea; Brendan M Darnell; David B Berkowitz
Journal:  J Am Chem Soc       Date:  2017-09-28       Impact factor: 15.419

5.  A formal [3,3]-sigmatropic rearrangement route to quaternary alpha-vinyl amino acids: use of allylic N-PMP trifluoroacetimidates.

Authors:  David B Berkowitz; Bin Wu; Huijie Li
Journal:  Org Lett       Date:  2006-03-02       Impact factor: 6.005

6.  Following an ISES lead: the first examples of asymmetric Ni(0)-mediated allylic amination.

Authors:  David B Berkowitz; Gourhari Maiti
Journal:  Org Lett       Date:  2004-08-05       Impact factor: 6.005

7.  Use of Fluorinated Functionality in Enzyme Inhibitor Development: Mechanistic and Analytical Advantages.

Authors:  David B Berkowitz; Kannan R Karukurichi; Roberto de la Salud-Bea; David L Nelson; Christopher D McCune
Journal:  J Fluor Chem       Date:  2008-09       Impact factor: 2.050

8.  Double nucleophilic addition to iminomalonate, leading to the synthesis of quaternary α-amino diesters and desymmetrization of the products.

Authors:  Makoto Shimizu; Miki Mushika; Isao Mizota; Yusong Zhu
Journal:  RSC Adv       Date:  2019-07-29       Impact factor: 4.036
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.